Asunto(s)
Clostridioides difficile , Infecciones por Clostridium , Trasplante de Microbiota Fecal , Trasplante de Microbiota Fecal/métodos , Humanos , Infecciones por Clostridium/terapia , Infecciones por Clostridium/microbiología , Resultado del Tratamiento , Masculino , Femenino , Persona de Mediana Edad , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéuticoRESUMEN
BACKGROUND AND STUDY AIMS: Gastric cancer (GC) is one of the major causes of cancer-related deaths worldwide. Helicobacter pylori (Hp) plays an important role in gastric carcinogenesis by inducing precancerous changes such as atrophic gastritis (AG) and intestinal metaplasia (IM). In our study, we aim to compare the grade of AG and IM before and after Hp eradication in patients who underwent esophagogastroduodenoscopy (EGD) in our center. PATIENTS AND METHODS: The data of 40.060 patients who underwent EGD for various reasons in our Endoscopy Unit between June 2011 and November 2017 were retrospectively evaluated. The grade of AG and IM before and after Hp eradication of patients meeting the study criteria were compared with each other. In addition, these findings were compared using OLGA and OLGIM staging systems. RESULTS: A total of 175 patients, 89 (50.9%) women and 86 (49.1%) men, were included in the study. The mean age was 55±12 years. The mean time between two EGD examinations was 38±14 months. Significant improvement was observed in the grade of AG on corpus and antrum after Hp eradication (P=0.000, P=0.008). In the corpus and antrum, the grade of IM was regressed but this was not significant (P=0.80 and P=0.370 respectively). There was a decrease in OLGA stages after Hp eradication (P=0.000). There was also a reduction in the OLGIM stages, but this was not significant(P=0.341). CONCLUSION: Our study demonstrates that Hp eradication may reduce the risk of developing GC by providing an improvement in AG and IM which are precancerous changes in GC.
Asunto(s)
Gastritis Atrófica , Infecciones por Helicobacter , Helicobacter pylori , Neoplasias Gástricas , Adulto , Anciano , Femenino , Gastritis Atrófica/microbiología , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/tratamiento farmacológico , Humanos , Masculino , Metaplasia , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
OBJECTIVE: Irritable bowel syndrome (IBS) is a common functional intestinal disorder. Although there are marked improvements in the conceptualization of IBS pathophysiology in brain-intestinal interaction disorder, there is no definite consensus in the role of autonomic dysfunction (AD) in disease development and symptom progression. The aim of this study was to evaluate autonomous dysfunction in IBS subgroups. PATIENTS AND METHODS: A total of 50 patients and 49 healthy controls were included. IBS subgroup types and demographic characteristics of patients were recorded. AD investigations were made up of parasympathetic and sympathetic tests. RESULTS: There was no statistically significant difference was determined between the groups in accordance to demographic characteristics such as age, gender, BMI and resting heart rate (p > 0.05). Three parasympathetic and one sympathetic autonomic neuropathy tests were found significantly different (respectively p < 0.001, p = 0.001, p = 0.016, p < 0.001, p = 0.375). There were significant decreases in parasympathetic tests in IBS-C patients; however, in the control group, there were significant decreases in sympathetic tests when compared with IBS-D patients (p < 0.001). The severity of AD in IBS-C subgroup was more pronounced than the IBS-D subgroup. No correlation was determined between dysautonomia and disease duration (p > 0.05). CONCLUSIONS: AD may have a role in IBS pathophysiology. Deterioration of the autonomous system not only affects the gastrointestinal system but also other systems including the cardiovascular system. Patients may also be susceptible to more diverse problems.
Asunto(s)
Enfermedades del Sistema Nervioso Autónomo/diagnóstico , Síndrome del Colon Irritable/clasificación , Síndrome del Colon Irritable/diagnóstico , Adulto , Sistema Nervioso Autónomo/fisiopatología , Enfermedades del Sistema Nervioso Autónomo/fisiopatología , Estudios de Cohortes , Electrocardiografía/métodos , Femenino , Humanos , Síndrome del Colon Irritable/fisiopatología , Masculino , Persona de Mediana EdadRESUMEN
In this study, treatment of cheese whey wastewater was performed using a uniquely-designed continuous electrocoagulation reactor, not previously encountered in the literature. An iron horizontal rotating screw type anode was used in the continuous mode. An empirical model, in terms of effective operational factors, such as current density (40, 50, 60 mA/cm(2)), pH (3, 5, 7) and retention time (20, 40, 60 min), was developed through Response Surface Methodology. An optimal region characterized by low values of Chemical Oxygen Demand (COD) was determined. As a result of experiments, a linear effect in the removal efficiency of COD was obtained for current density and retention time, while the initial pH of the wastewater was found to have a quadratic effect in the removal efficiency of COD. The best fit nonlinear mathematical model, with a coefficient of determination value (R(2)) of 85%, was defined. An initial COD concentration of 15.500 mg/L was reduced to 2112 mg/L with a removal efficiency of 86.4%. In conclusion, it can be said that electrocoagulation was successfully applied for the treatment of cheese whey wastewater.
Asunto(s)
Proteínas de la Leche/química , Eliminación de Residuos Líquidos/métodos , Aguas Residuales , Contaminantes Químicos del Agua/química , Queso , Electrocoagulación/métodos , Humanos , Concentración de Iones de Hidrógeno , Purificación del Agua/métodosRESUMEN
Eosinophilic esophagitis (EoE) is a chronic, immune/antigen-mediated esophageal disease characterized with symptoms related to esophageal dysfunction and eosinophil-predominant inflammation. There has been a dramatic increase in the diagnosis of this disease in recent years. The primary objective of this study was to determine the frequency of EoE in adult patients who were evaluated by gastroenterologists in our clinic with esophageal symptoms. Between November 2010 and May 2011, 311 adult patients who were evaluated in our clinic with esophageal symptoms were enrolled prospectively. All patients underwent endoscopy and had biopsies taken. Gastroesophageal reflux disease was excluded by either proton pump inhibitory treatment or 24-hour ambulatory pH monitorization. The diagnosis was confirmed by one independent pathologist. Frequency of EoE in patients with esophageal symptoms was 2.6% (n = 8; four men and four women). Mean age at diagnosis was 40.2 ± 8 years. Heartburn was the predominant symptom in patients (75% of the patients), and 87.5% (n = 7) of patients had more than one symptom at diagnosis. Nearly 38% of the patients (n = 3) had a history of allergic disease. Endoscopic findings were as follows: transient/fixed esophageal rings (25%), white exudates (25%), and normal appearance (50%). Median number of circulating eosinophils was 208 (93-659)/mm(3) . Median number of intraepithelial eosinophils in proximal-middle 1/3 part and distal 1/3 part of esophagus were 0 (0-50)/hpf and 37 (16-50)/hpf, respectively. In conclusion, EoE is not rare in Turkey, and it should be considered in the differential diagnosis of patients with esophageal symptoms.
Asunto(s)
Trastornos de Deglución/epidemiología , Esofagitis Eosinofílica/epidemiología , Pirosis/epidemiología , Reflujo Laringofaríngeo/epidemiología , Adulto , Asma/epidemiología , Biopsia , Estudios de Cohortes , Trastornos de Deglución/patología , Hipersensibilidad a las Drogas/epidemiología , Esofagitis Eosinofílica/patología , Eosinófilos/patología , Esofagoscopía , Esófago/patología , Femenino , Hipersensibilidad a los Alimentos/epidemiología , Pirosis/patología , Humanos , Reflujo Laringofaríngeo/patología , Masculino , Persona de Mediana Edad , Rinitis Alérgica , Rinitis Alérgica Perenne/epidemiología , Turquía/epidemiologíaAsunto(s)
Colangitis/etiología , Colecistectomía/efectos adversos , Colecistectomía/instrumentación , Enfermedades del Conducto Colédoco/etiología , Migración de Cuerpo Extraño/diagnóstico , Migración de Cuerpo Extraño/etiología , Anciano de 80 o más Años , Bilis , Colangitis/diagnóstico , Colangitis/terapia , Enfermedades del Conducto Colédoco/diagnóstico , Enfermedades del Conducto Colédoco/terapia , Migración de Cuerpo Extraño/terapia , Humanos , MasculinoRESUMEN
UNLABELLED: Patients with end-stage renal disease are at high risk for exposure to hepatitis C virus (HCV) infection. Although both viral replication and liver disease progression are accelerated after renal transplantation, the long-term impact of chronic HCV infection is unclear. Our aim was to analyze the course of HCV infection in renal transplant recipients and the effects of HCV reactivation on patient and graft survival. METHODS: We retrospectively examined the 21-year (1985-2006) data of 1274 renal transplant recipients, 43 of whom were anti-HCV positive at the time of transplantation. RESULTS: The mean posttransplant follow-up of 43 patients was 62.0 +/- 7.3 months. At the time of transplantation, HCV RNA was positive in 11 (25.6%) patients and negative in 32 (74.4%) patients. HCV reactivation was seen in 19 (45.2%) patients at a mean time of 20.8 +/- 5.7 months. In 31 (72%) patients, acute rejection occurred, whereas graft loss occurred in 10 (23%) patients. Three (7%) patients died. Among 43 patients, 22 (51.2%) were treated with interferon before transplantation. There was a statistically significant association between pretransplant interferon therapy and pretransplant HCVRNA level (P=.024), but no significant association of HCV reactivation and graft rejection, mortality, or kidney survival. CONCLUSION: HCV reactivation occurred in nearly half of the renal transplant recipients, mostly in the second year. Patient survival and graft survival were not affected by HCV reactivation. Anti-HCV positivity should not preclude chronic renal failure patients from renal transplantation.
Asunto(s)
Hepatitis C/fisiopatología , Trasplante de Riñón/fisiología , Complicaciones Posoperatorias/virología , Adolescente , Adulto , Biopsia , Femenino , Estudios de Seguimiento , Hepatitis C/epidemiología , Hepatitis C/patología , Humanos , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/cirugía , Hígado/patología , Hígado/virología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Tiempo , Turquía/epidemiologíaRESUMEN
Fat embolism syndrome is a rare, but life-threatening problem and is usually associated with severe trauma. Neurological symptoms are variable, and the clinical diagnosis is difficult. We describe a patient with fat density lesions on cranial CT sections and discuss the etiopathogenesis of cerebral fat embolism (CFE) in this patient who does not have a history of long bone fracture, but metastatic lung disease and empyema. This is probably the first case report of CFE secondary to pleural irrigation of empyema with demonstrative CT findings.